Sino Biopharmaceutical | 1177 - Gross Profit On Sales

Stock Price
6.48
Daily Change
0.05 0.78%
Monthly
-5.12%
Yearly
118.18%
Q1 Forecast
6.37

Sino Biopharmaceutical reported CNY10.5B in Gross Profit on Sales for its fiscal semester ending in December of 2024.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.95M 1.18M Jun/2025
Cspc Pharmaceutical CNY 4.34B 333.68M Sep/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Jiangsu Hengrui CNY 6.36B 1.15B Sep/2025
Moderna USD 809M 791M Sep/2025
Organon & Co USD 857M 17M Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.37B 38.6M Sep/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025